Skip to main content
. 2023 Jun 29;61:102068. doi: 10.1016/j.eclinm.2023.102068

Table 1.

Demographic and clinical characteristics at baseline by hearing loss status.

Characteristics
Not standardized for age-sex strata
Standardized for age-sex strata
Hearing loss No hearing loss Hearing loss No hearing loss
N 152,766 4,571,880
Age, ya 52.4 [17.5] 36.5 [17.1]
Male 76,453 (50.0) 2,332,302 (51.0)
Rural residence 15,041 (10.1) 413,313 (10.3) 13,554 (9.3) 414,005 (10.4)
Material deprivationa 3.1 [1.4] 3.2 [1.4] 3.1 [1.5] 3.2 [1.4]
Morbidities
 Obesity 18,333 (13.2) 338,895 (11.6) 16,383 (12.2) 340,470 (11.6)
 Hypertension 40,959 (26.8) 408,808 (8.9) 32,704 (21.7) 418,317 (9.2)
 Chronic pain 30,143 (19.7) 337,071 (7.4) 24,922 (16.5) 342,275 (7.5)
 Depression 16,461 (10.8) 208,424 (4.6) 14,052 (9.3) 210,523 (4.6)
 Diabetes 11,663 (7.6) 132,681 (2.9) 9669 (6.4) 135,233 (3.0)
 Chronic pulmonary 14,686 (9.6) 138,431 (3.0) 11,647 (7.7) 141,100 (3.1)
 Hypothyroid 10,997 (7.2) 113,098 (2.5) 8762 (5.8) 115,342 (2.5)
 Osteoporosis 10,604 (6.9) 94,511 (2.1) 8241 (5.5) 96,571 (2.1)
 Gout 7142 (4.7) 74,502 (1.6) 5721 (3.8) 76,221 (1.7)
 Stroke/TIA 7165 (4.7) 59,398 (1.3) 5650 (3.7) 60,635 (1.3)
 Fragility fracture 3956 (2.6) 49,223 (1.1) 3168 (2.1) 49,972 (1.1)
 Cancer 4285 (2.8) 41,989 (0.9) 3452 (2.3) 42,858 (0.9)
 Chronic heart failure 4746 (3.1) 46,889 (1.0) 3871 (2.6) 47,685 (1.0)
 Alcohol misuse 2396 (1.6) 43,152 (0.9) 2072 (1.4) 43,573 (1.0)
 Asthma 3801 (2.5) 42,472 (0.9) 3052 (2.0) 43,061 (0.9)
 Atrial fibrillation 4108 (2.7) 35,914 (0.8) 3261 (2.2) 36,656 (0.8)
 Coronary artery d. 4343 (2.8) 37,322 (0.8) 3350 (2.2) 38,337 (0.8)
 Irritable bowel s. 3040 (2.0) 26,157 (0.6) 2374 (1.6) 26,625 (0.6)
 Epilepsy 1801 (1.2) 22,860 (0.5) 1533 (1.0) 23,113 (0.5)
 Rheumatic d. 2746 (1.8) 23,570 (0.5) 2109 (1.4) 24,094 (0.5)
 Dementia 1703 (1.1) 19,662 (0.4) 1484 (1.0) 19,829 (0.4)
 Schizophrenia 1150 (0.8) 18,571 (0.4) 973 (0.6) 18,786 (0.4)
 Severe constipation 1118 (0.7) 10,310 (0.2) 917 (0.6) 10,456 (0.2)
 Inflammatory bowel d. 1200 (0.8) 15,612 (0.3) 987 (0.7) 15,828 (0.3)
 Multiple sclerosis 758 (0.5) 10,969 (0.2) 606 (0.4) 11,154 (0.2)
 Peripheral arterial d. 1026 (0.7) 9240 (0.2) 800 (0.5) 9412 (0.2)
 Psoriasis 649 (0.4) 7737 (0.2) 523 (0.3) 7886 (0.2)
 Parkinson's d. 732 (0.5) 7812 (0.2) 583 (0.4) 7936 (0.2)
 Severe CKD 360 (0.2) 4008 (0.1) 316 (0.2) 4043 (0.1)
 Peptic ulcer d. 341 (0.2) 3443 (0.1) 277 (0.2) 3493 (0.1)
 Liver d. 182 (0.1) 2995 (0.1) 163 (0.1) 3016 (0.1)
Complexity markers
 Number of morbiditiesa 1.3 [1.6] 0.4 [1.0] 1.0 [1.5] 0.5 [1.0]
 Mental health condition 18,486 (11.8) 247,447 (5.3) 15,800 (10.4) 249,964 (5.4)
 Number of prescriptionsa 0.3 [3.4] 1.0 [6.0] 1.0 [6.1] 1.0 [5.9]
 Types of physiciansa 2.3 [1.7] 1.4 [1.3] 2.3 [1.7] 1.4 [1.3]
 Number of physiciansa 4.0 [3.7] 2.5 [3.0] 4.1 [3.7] 2.5 [3.0]

CKD, Chronic kidney disease; d, Disease; s, Syndrome; SD, Standard deviation; TIA, Transient ischemic attack.

N (%) or mean [SD] as appropriate. All characteristics were obtained at baseline. Participants in the group with hearing loss developed hearing loss at some point during follow-up. The age-sex strata are created using 5-year intervals of age. The differences between the groups were tested by regressing hearing loss onto each covariate in term, not weighted or weighted by age-sex strata, using logistic regression. All differences were significant at p < 0.001 except for the following: rural residence had a p = 0.007 for percentages that were not standardized for age-sex strata, and number of prescriptions had a p = 0.85 for means that were standardized for age-sex strata.

a

Mean [SD].